Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia
Abstract Background Tumour dormancy, a resistance mechanism employed by cancer cells, is a significant challenge in cancer treatment, contributing to minimal residual disease (MRD) and potential relapse. Despite its clinical importance, the mechanisms underlying tumour dormancy and MRD remain unclea...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Article |
語言: | English |
出版: |
BMC
2024-09-01
|
叢編: | Biological Research |
主題: | |
在線閱讀: | https://doi.org/10.1186/s40659-024-00540-y |